Albumod

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

Affibody molecule: A molecule that can detect breast cancer

By AWA | Posted on October 31, 2018

Every month is breast cancer awareness month for Swedish Biopharmaceutical R&D company Affibody, which has developed unique molecular technologies to localise cancerous tumours and individualise drug treatment for patients Director of Alliance and IP Management at Affibody Caroline Ekblad has been with the Solna based company since 2007. She started out working with research, but...

Tags: Affibody, Albumod, biopharmaceuticals, breast cancer, cancer, diagnostics, Intellectual Property, molecules, patents

Recent contributors

Laura Stravinskaite

Laura Stravinskaite

Senior Associate, Attorney at Law

Ai-Leen Lim

Ai-Leen Lim

Partner, Attorney at Law, Group Vice President

Ashley Zhao

Ashley Zhao

Partner, Attorney at Law, Business Area Manager

Troels Peter Rørdam

Troels Peter Rørdam

Senior Counsel, European Patent Attorney

Mikkel Roed Trier

Mikkel Roed Trier

Partner, European Patent Attorney, UPC Representative, Business Area Manager